Daryll Vanover

Daryll Vanover

Georgia Institute of Technology

H-index: 18

North America-United States

About Daryll Vanover

Daryll Vanover, With an exceptional h-index of 18 and a recent h-index of 18 (since 2020), a distinguished researcher at Georgia Institute of Technology, specializes in the field of RNA therapeutics, infectious disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Synthetic antigens as chimeric antigen receptor (car) ligands and uses thereof

A direct contact pig influenza challenge model for assessing protective efficacy of monoclonal antibodies

High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo

Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung

Mrna-encoded antibodies for contraception

PP 1.38–00212 Characterization of SIV infected mast cells in early foci of rebound after ATI and HIV infection of primary mast cells in tissue culture models reveals an …

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles

Daryll Vanover Information

University

Position

Research Scientist

Citations(all)

1571

Citations(since 2020)

1463

Cited By

452

hIndex(all)

18

hIndex(since 2020)

18

i10Index(all)

20

i10Index(since 2020)

20

Email

University Profile Page

Google Scholar

Daryll Vanover Skills & Research Interests

RNA therapeutics

infectious disease

Top articles of Daryll Vanover

Synthetic antigens as chimeric antigen receptor (car) ligands and uses thereof

2023/12/7

A direct contact pig influenza challenge model for assessing protective efficacy of monoclonal antibodies

Frontiers in Immunology

2023/10/27

High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo

Journal of Controlled Release

2023/5/1

Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung

Nature materials

2023/3

Mrna-encoded antibodies for contraception

2023/1/5

PP 1.38–00212 Characterization of SIV infected mast cells in early foci of rebound after ATI and HIV infection of primary mast cells in tissue culture models reveals an …

2022

Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Advanced Science

2022/12

Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles

Nature nanotechnology

2022/3

Sensitizing solid tumors to CAR-mediated cytotoxicity using synthetic antigens

bioRxiv

2021/12/12

Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART

JCI insight

2021/12/12

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

Nature biomedical engineering

2021/9

Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents

Nature biotechnology

2021/6

Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells

Journal of neuroinflammation

2020/12

Polymerase-tagged respiratory syncytial virus reveals a dynamic rearrangement of the ribonucleocapsid complex during infection

PLoS pathogens

2020/10/8

Daryll Vanover
Daryll Vanover

H-Index: 10

Chiara Zurla
Chiara Zurla

H-Index: 17

Treating influenza and SARS-CoV-2 via mRNA-encoded Cas13a

bioRxiv

2020/4/24

Aerosol delivery of synthetic mRNA to vaginal mucosa leads to durable expression of broadly neutralizing antibodies against HIV

Molecular Therapy

2020/3/4

See List of Professors in Daryll Vanover University(Georgia Institute of Technology)